-
What Is Non-radiographic Axial Spondyloarthritis?
18 Jul 2025 14:22 GMT
… diagnosis, potentially delaying treatment.
Take non-radiographic axial spondyloarthritis (nr-axSpA). … learn about a disease called ankylosing spondylitis (AS). The inflammatory condition … gut issues: Some patients may develop an inflammatory bowel disease, …
-
Bio-Thera Solutions Announces FDA Accepts Biologics License Application For BAT2506, A Proposed Biosimilar To Simponi®
16 Jul 2025 12:37 GMT
… . Food and Drug Administration (FDA) has accepted … arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. … and developing novel therapeutics for the treatment of … uncertainties inherent in pharmaceutical research and development, such as …
-
Zydus' Non-Steroidal Painkiller Receives FDA Final Nod
15 Jul 2025 22:51 GMT
… its nonsteroidal anti-inflammatory drug (NSAID), Celecoxib, has … .S. Food and Drug Administration (FDA).
Celecoxib is used … arthritis, ankylosing spondylitis, and menstrual pain.
The approved drug is the … of 492 Abbreviated New Drug Applications (ANDAs) since …
-
JAK1 Inhibitor Shows Promise for Ankylosing Spondylitis
01 Jul 2025 06:51 GMT
… caused few treatment discontinuations.
IN … drugs used for active ankylosing spondylitis. … These findings in Chinese patients with radiographic axial spondyloarthritis … Pharmaceuticals Co. Ltd. sponsored and designed the trial …
-
Lupin, Zentiva ink pact to commercialize arthritis drug Certolizumab Pegol
09 Jul 2025 11:00 GMT
… indicated for the treatment of patients with rheumatoid … , non-radiographic axial spondyloarthritis, moderate-to-severe plaque … Egros, President of Corporate Development, Lupin. “This partnership … products, and active pharmaceutical ingredients.The company has …
-
Ankylosing Spondylitis Market to Reach $8.1 Billion by 2030
25 Jun 2025 08:33 GMT
… treatment, particularly in developing countries.
🦴 What Is Ankylosing Spondylitis?
Ankylosing spondylitis … drugs
🧪 Market Segmentation Overview
💊 By Drug … Distribution Channel
Retail Pharmacies (Leading Channel … availability of FDA-approved therapies …
-
Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use to Rare Blood Vessel Disorder
06 Jul 2025 16:41 GMT
… aneurysms.
Standard treatment for GCA is … inflammation that develops in multiple autoimmune … steroid tapering, treating GCA by … drug has landed additional FDA approvals in ankylosing spondylitis, psoriatic arthritis, non-radiographic axial spondyloarthritis …
-
Immunomodulator Therapeutics Global Market Research 2024-2030 | R&D Investments Fuel Next-Gen Immunomodulator Development Amid Patent Expiry - ResearchAndMarkets.com
04 Jul 2025 10:58 GMT
… , and ankylosing spondylitis, started … treatment discontinuation … Drug Development Trends - I&I
Trial Landscape
Clinical Trial … Pharmaceuticals
Astellas Pharma
Takeda
Chugai Pharma
Mitsubishi Chemical
Sun Pharmaceutical Industries
Shanghai Pharmaceuticals …
-
Novartis drug flunks phase 3 test in giant cell arteritis
03 Jul 2025 12:53 GMT
… immunology drug Cosentyx has disappointed in a phase 3 trial … likely to develop visual symptoms.
For many years, treatment for GCA … are already approved by the FDA for GCA.
In 2017, … arthritis, and ankylosing spondylitis and has turned the drug into a $6 …
-
Lateral Epicondylitis Treatment Market Report 2025 – Strategic Insights For Companies Seeking Expansion and Growth
03 Jul 2025 16:33 GMT
… non-invasive treatment options, the development of regenerative … , Cleveland Clinic, Chugai Pharmaceutical, Johns Hopkins Medicine, … growth factors, to treat various medical conditions … #47;report/ankylosing-spondylitis-global-market-report
About …